275 related articles for article (PubMed ID: 20942940)
1. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
[TBL] [Abstract][Full Text] [Related]
5. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
8. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
Trials; 2013 Nov; 14():378. PubMed ID: 24206639
[TBL] [Abstract][Full Text] [Related]
9. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
[TBL] [Abstract][Full Text] [Related]
10. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
[TBL] [Abstract][Full Text] [Related]
11. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
Ott CV; Vinberg M; Kessing LV; Miskowiak KW
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
[TBL] [Abstract][Full Text] [Related]
12. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
[TBL] [Abstract][Full Text] [Related]
13. Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.
Luckenbaugh DA; Ameli R; Brutsche NE; Zarate CA
J Psychiatr Res; 2015 Feb; 61():40-5. PubMed ID: 25592045
[TBL] [Abstract][Full Text] [Related]
14. The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
Vinberg M; Miskowiak K; Hoejman P; Pedersen M; Kessing LV
PLoS One; 2015; 10(5):e0127629. PubMed ID: 26011424
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey ML; Drevets WC
Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
[TBL] [Abstract][Full Text] [Related]
16. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
17. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
[TBL] [Abstract][Full Text] [Related]
18. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
[TBL] [Abstract][Full Text] [Related]
19. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.
Smith J; Browning M; Conen S; Smallman R; Buchbjerg J; Larsen KG; Olsen CK; Christensen SR; Dawson GR; Deakin JF; Hawkins P; Morris R; Goodwin G; Harmer CJ
Mol Psychiatry; 2018 May; 23(5):1127-1133. PubMed ID: 28533517
[TBL] [Abstract][Full Text] [Related]
20. Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
Macoveanu J; Petersen JZ; Mariegaard J; Jespersen AE; Cramer K; Bruun CF; Madsen HØ; Jørgensen MB; Vinberg M; Fisher PM; Knudsen GM; Hageman I; Ehrenreich H; Kessing LV; Miskowiak KW
J Psychopharmacol; 2024 Apr; 38(4):362-374. PubMed ID: 38519416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
